MedPath

Nafcillin

Generic Name
Nafcillin
Drug Type
Small Molecule
Chemical Formula
C21H22N2O5S
CAS Number
147-52-4
Unique Ingredient Identifier
4CNZ27M7RV

Overview

A semi-synthetic antibiotic related to penicillin, Naficillin is a narrow-spectrum beta-lactam antibiotic drug. It is a beta-lactamase-resistant penicillin that is indicated for the treatment of Staphylococcal infections caused by strains that are resistant to other penicillins, except those caused by MRSA. It may be used as a first-line therapy in Methicillin-Sensitive Staphylococcus aureus infections .

Background

A semi-synthetic antibiotic related to penicillin, Naficillin is a narrow-spectrum beta-lactam antibiotic drug. It is a beta-lactamase-resistant penicillin that is indicated for the treatment of Staphylococcal infections caused by strains that are resistant to other penicillins, except those caused by MRSA. It may be used as a first-line therapy in Methicillin-Sensitive Staphylococcus aureus infections .

Indication

Indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug.

Associated Conditions

  • Bacterial Infections

FDA Approved Products

NAFCILLIN
Manufacturer:Baxter Healthcare Corporation
Route:INTRAVENOUS
Strength:2 g in 100 mL
Approved: 2017/07/14
NDC:0338-1019
Nafcillin
Manufacturer:Sagent Pharmaceuticals
Route:INTRAVENOUS, INTRAMUSCULAR
Strength:1 g in 4 mL
Approved: 2018/05/16
NDC:25021-139
NAFCILLIN SODIUM
Manufacturer:Steriscience Specialties Private Limited
Route:INTRAMUSCULAR, INTRAVENOUS
Strength:1 g in 1 1
Approved: 2023/10/17
NDC:82449-503
Nafcillin
Manufacturer:Athenex Pharmaceutical Division, LLC.
Route:INTRAVENOUS
Strength:10 g in 100 mL
Approved: 2024/03/04
NDC:70860-119
Nafcillin
Manufacturer:Fresenius Kabi USA, LLC
Route:INTRAMUSCULAR, INTRAVENOUS
Strength:2 g in 8 mL
Approved: 2019/05/24
NDC:63323-328

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath